Patient-Based Therapeutics

AcuraStem is a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases — including sporadic ALS and FTD — using our proprietary, best-in-class, disease-modeling platform, iNeuroRx®, the gold standard for discovering novel, effective and broadly-acting treatments.

get to know us

Patient Focused

rp3.jpgrp1.jpgrp2.jpg

rp4.jpgThe main reason drugs fail in clinical trials is due to an over reliance on animal models, which leads to a poor understanding of the real human mechanisms driving disease. AcuraStem are leaders and inventors in the generation of individual patient models that accurately recapitulate neurodegenerative disease processes. This, what we call our patient-based approach, leads to more effective treatments, and treatments that can work broadly for patients, not limited to rare, genetically defined subtypes. 


learn about our work

Neurodegenerative Disease Areas

Latest News

November 8, 2019

2019 Viva Biotech Partnership Summit

Nov 8-10, 2019, Shanghai, China: Co-Founders Sam Alworth and Dr. Qing Liu will be speaking on November 9th, 2019 at this prestigious summit for innovators on the "Future of Drug Discovery for CNS Indications."

» Read more
November 7, 2019

AcuraStem Partners with Team Nanci and The ALS Association Golden West Chapter at LA Walk to Defeat ALS

AcuraStem was honored to once again partner with Team Nanci and the ALS Association Golden West Chapter in the fight against ALS as a sponsor of the 17th Annual Los Angeles County Walk to Defeat ALS® on Sunday, November 3, at Exposition Park in Los Angeles.

» Read more
November 3, 2019

Walk to Defeat ALS, Golden West Chapter

Nov 3rd, 2019, Walk to Defeat ALS, Golden West Chapter: Team AcuraStem is fundraising for Team Nanci and the whole team will walk in LA on November 3rd. Come by our booth!

» Read more

Keep Up to Date with AcuraStem